HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $190.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 44.43% from the company’s current price. Several other research […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $190.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 44.43% from the company’s current price. Several other research […]
